Literature DB >> 19406968

Clinical outcomes of dialysis catheter-related candidemia in hemodialysis patients.

Dmitri Sychev1, Ivan D Maya, Michael Allon.   

Abstract

BACKGROUND AND OBJECTIVES: Candidemia is a rare complication in catheter-dependent hemodialysis patients. As a result, there is uncertainty about its optimal medical management. The goal of this retrospective study was to compare the clinical outcomes of catheter-related candidemia managed with two different strategies: Guidewire exchange of the infected catheter versus removal with delayed replacement. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We retrospectively queried a prospective, computerized vascular access database to identify 40 hemodialysis patients with catheter-related candidemia. All patients underwent treatment with antifungal medications for 2 wk, in conjunction with guidewire catheter exchange or catheter removal with delayed replacement. The primary outcomes were major complications, recurrent candidemia, and patient survival.
RESULTS: Candidemia represented approximately 2% of all cases of catheter-related bloodstream infections. Of the 40 patients with candidemia, 27 underwent guidewire catheter exchange and 13 had prompt catheter removal with delayed replacement. The two treatment groups were similar in demographic, clinical, and catheter characteristics. Only 1 (2.5%) patient developed a serious complication (endophthalmitis). Recurrence of candidemia within 3 mo was observed in 15% of each treatment group. Patient survival at 6 mo was similar in both groups.
CONCLUSIONS: Catheter-related candidemia is rare in hemodialysis patients and has a low complication rate. Catheter exchange over a guidewire in conjunction with antifungal therapy is an effective and safe treatment regimen.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19406968      PMCID: PMC2689884          DOI: 10.2215/CJN.01610309

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  19 in total

1.  National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathogens of Epidemiologic.

Authors:  M A Pfaller; R N Jones; S A Messer; M B Edmond; R P Wenzel
Journal:  Diagn Microbiol Infect Dis       Date:  1998-02       Impact factor: 2.803

2.  A multidisciplinary approach to hemodialysis access: prospective evaluation.

Authors:  M Allon; R Bailey; R Ballard; M H Deierhoi; K Hamrick; R Oser; V K Rhynes; M L Robbin; S Saddekni; S T Zeigler
Journal:  Kidney Int       Date:  1998-02       Impact factor: 10.612

3.  Treatment of infected tunneled venous access hemodialysis catheters with guidewire exchange.

Authors:  D Robinson; P Suhocki; S J Schwab
Journal:  Kidney Int       Date:  1998-06       Impact factor: 10.612

4.  Catheter-related sepsis complicating long-term, tunnelled central venous dialysis catheters: management by guidewire exchange.

Authors:  D Shaffer
Journal:  Am J Kidney Dis       Date:  1995-04       Impact factor: 8.860

5.  The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.

Authors:  M H Nguyen; J E Peacock; A J Morris; D C Tanner; M L Nguyen; D R Snydman; M M Wagener; M G Rinaldi; V L Yu
Journal:  Am J Med       Date:  1996-06       Impact factor: 4.965

6.  Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital.

Authors:  R Luzzati; G Amalfitano; L Lazzarini; F Soldani; S Bellino; M Solbiati; M C Danzi; S Vento; G Todeschini; C Vivenza; E Concia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-08       Impact factor: 3.267

Review 7.  Dialysis catheter-related bacteremia: treatment and prophylaxis.

Authors:  Michael Allon
Journal:  Am J Kidney Dis       Date:  2004-11       Impact factor: 8.860

8.  Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.

Authors:  J H Rex; J E Bennett; A M Sugar; P G Pappas; J Serody; J E Edwards; R G Washburn
Journal:  Clin Infect Dis       Date:  1995-10       Impact factor: 9.079

9.  Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study.

Authors:  M H Nguyen; J E Peacock; D C Tanner; A J Morris; M L Nguyen; D R Snydman; M M Wagener; V L Yu
Journal:  Arch Intern Med       Date:  1995 Dec 11-25

10.  A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

Authors:  John H Rex; Peter G Pappas; Adolf W Karchmer; Jack Sobel; John E Edwards; Susan Hadley; Corstiaan Brass; Jose A Vazquez; Stanley W Chapman; Harold W Horowitz; Marcus Zervos; David McKinsey; Jeannette Lee; Timothy Babinchak; Robert W Bradsher; John D Cleary; David M Cohen; Larry Danziger; Mitchell Goldman; Jesse Goodman; Eileen Hilton; Newton E Hyslop; Daniel H Kett; Jon Lutz; Robert H Rubin; W Michael Scheld; Mindy Schuster; Bryan Simmons; David K Stein; Ronald G Washburn; Linda Mautner; Teng-Chiao Chu; Helene Panzer; Rebecca B Rosenstein; Jenia Booth
Journal:  Clin Infect Dis       Date:  2003-05-08       Impact factor: 9.079

View more
  7 in total

1.  Vascular access infections: epidemiology, diagnosis, and management.

Authors:  Jacob A Akoh
Journal:  Curr Infect Dis Rep       Date:  2011-08       Impact factor: 3.725

2.  Restoring glucose uptake rescues neutrophil dysfunction and protects against systemic fungal infection in mouse models of kidney disease.

Authors:  Chetan V Jawale; Kritika Ramani; De-Dong Li; Bianca M Coleman; Rohan S Oberoi; Saran Kupul; Li Lin; Jigar V Desai; Greg M Delgoffe; Michail S Lionakis; Filitsa H Bender; Alexander J Prokopienko; Thomas D Nolin; Sarah L Gaffen; Partha S Biswas
Journal:  Sci Transl Med       Date:  2020-06-17       Impact factor: 17.956

3.  Caspofungin at catheter lock concentrations eradicates mature biofilms of Candida lusitaniae and Candida guilliermondii.

Authors:  Maria Simitsopoulou; Daniela Kyrpitzi; Aristea Velegraki; Thomas J Walsh; Emmanuel Roilides
Journal:  Antimicrob Agents Chemother       Date:  2014-06-02       Impact factor: 5.191

4.  Treatment guidelines for dialysis catheter-related bacteremia: an update.

Authors:  Michael Allon
Journal:  Am J Kidney Dis       Date:  2009-07       Impact factor: 8.860

Review 5.  Could Histoplasma capsulatum Be Related to Healthcare-Associated Infections?

Authors:  Laura Elena Carreto-Binaghi; Lisandra Serra Damasceno; Nayla de Souza Pitangui; Ana Marisa Fusco-Almeida; Maria José Soares Mendes-Giannini; Rosely Maria Zancopé-Oliveira; Maria Lucia Taylor
Journal:  Biomed Res Int       Date:  2015-05-27       Impact factor: 3.411

6.  How to deal with dialysis catheters in the ICU setting.

Authors:  Natacha Mrozek; Alexandre Lautrette; Jean-François Timsit; Bertrand Souweine
Journal:  Ann Intensive Care       Date:  2012-11-23       Impact factor: 6.925

Review 7.  Prevention of catheter-related bloodstream infections in patients on hemodialysis: challenges and management strategies.

Authors:  Vivek Soi; Carol L Moore; Lalathakasha Kumbar; Jerry Yee
Journal:  Int J Nephrol Renovasc Dis       Date:  2016-04-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.